URGENCIAS: 800 999 8743

URGENCIAS: 800 999 8743

El uso de cubrebocas es obligatorio durante tu estancia en el hospital

¡Seguimos cuidando tu salud! Recuerda: el uso de cubrebocas es obligatorio durante tu estancia en el hospital; con esto evitamos la propagación de enfermedades respiratorias.

Fundación Clínica Médica Sur
Ir a Fundación clínica - Investigación

Áreas de Investigación:

Publicaciones anteriores

  • Juárez-Hernández E, Velázquez-Alemán AP, Castro-Narro G, Uribe M, López-Méndez I. Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments? Front Endocrinol (Lausanne). 2022 Nov 29;13:1026444.
    doi: 10.3389/fendo.2022.1026444. eCollection 2022
    https://pubmed.ncbi.nlm.nih.gov/36523596/
  • Ordoñez-Vázquez AL, Juárez-Hernández E, Zuarth-Vázquez JM, Ramos-Ostos MH, Uribe M, Castro-Narro G, López-Méndez I. Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients. Int J Environ Res Public Health. 2022 Sep 27;19(19):12221.
    doi: 10.3390/ijerph191912221
    https://pubmed.ncbi.nlm.nih.gov/36231529/
  • Vidal-Cevallos P, Chávez-Tapia NC, Uribe M. Current approaches to hepatic encephalopathy. Ann Hepatol. 2022 Nov-Dec;27(6):100757.
    doi: 10.1016/j.aohep.2022.100757
    https://pubmed.ncbi.nlm.nih.gov/36115576/
  • López-Sánchez GN, Montalvo-Javé E, Domínguez-Perez M, Antuna-Puente B, Beltrán-Anaya FO, Hidalgo-Miranda A, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Hepatic mir-122-3p, mir-140-5p and mir-148b-5p expressions are correlated with cytokeratin-18 serum levels in MAFLD. Ann Hepatol. 2022 Nov-Dec;27(6):100756.
    doi: 10.1016/j.aohep.2022.100756
    https://pubmed.ncbi.nlm.nih.gov/36096296/
  • Aquino-Matus J, Uribe M, Chavez-Tapia N. COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases-A Concise Review. Trop Med Infect Dis. 2022 Aug 16;7(8):187.
    doi: 10.3390/tropicalmed7080187
    https://pubmed.ncbi.nlm.nih.gov/36006279/
  • Chavez-Tapia NC, Murúa-Beltrán Gall S, Ordoñez-Vázquez AL, Nuño-Lambarri N, Vidal-Cevallos P, Uribe M. Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2022 Jul 5;9:583-593.
    doi: 10.2147/JHC.S283840
    https://pubmed.ncbi.nlm.nih.gov/35818404/
  • Montgomery H, Hobbs FDR, Padilla F, Arbetter D, Templeton A, Seegobin S, Kim K, Campos JAS, Arends RH, Brodek BH, Brooks D, Garbes P, Jimenez J, Koh GCKW, Padilla KW, Streicher K, Viani RM, Alagappan V, Pangalos MN, Esser MT, Abe W, Adan De Varona T, Adiatullina D, Aguilar Zapata D, Ahlers K, Aimo C, Akere A, Akimova E, Alatorre-Alexander J, Aldrich L, Ali- Garcia I, Ali-García K, Allison L, Alonso-Zuñiga R, Aloysius I, Altclas J, Alvarisqueta A, Antila M, Anton C, Árboix-Alamo E, Arora S, Ramón Alejandro Avilés-Felix RA, Bakhtina N, Barbero-Becerra V, et al. Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2022 Oct;10(10):985-996.
    doi: 10.1016/S2213-2600(22)00180-1
    https://pubmed.ncbi.nlm.nih.gov/35688164/
  • Chavez-Tapia NC, Barrientos-Gutierrez T, Torres-Ibarra L, Sanchez-Jiménez B, Juarez-Hernandez E, Ramos-Ostos M, Alva-Lopez LF, Uribe M. Incremental levels of diagnostic information incentivize health-seeking in non-alcoholic fatty liver: a randomized clinical trial. Sci Rep 2022 May 18;12(1):8272.
    doi: 10.1038/s41598-022-12295-1
    https://pubmed.ncbi.nlm.nih.gov/35585153/
  • Díaz LA, Fuentes-López E, Ayares G, Idalsoaga F, Arnold J, Márquez-Lomas A, Ramírez CA, Medel MP, Viñuela F, Lacalle L, Roblero JP, Ferreccio C, Lazo M, Brahmania M, Singal AK, Dirchwolf M, Méndez-Sánchez N, Chavez-Tapia N, Guerra P, Restrepo JC, Oliveira CP, Lombardo J, Sánchez A, Elizondo M, Tagle M, Padilla M, Sánchez M, Carrera E, Girala M, Chery O, Castellanos-Fernández M, Barrera F, Lazarus JV, Kamath PS, Bataller R, Arrese M, Arab JP. The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas. Lancet Gastroenterol Hepatol. 2022 Jun;7(6):552-559.
    doi: 10.1016/S2468-1253(22)00008-5
    https://pubmed.ncbi.nlm.nih.gov/35430032/
  • Aguilar-Zamora E, Weimer BC, Torres RC, Gómez-Delgado A, Ortiz-Olvera N, Aparicio-Ozores G, Barbero-Becerra VJ, Torres J, Camorlinga-Ponce M. Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico. Front Microbiol. 2022 Mar 10;12:787451.
    doi: 10.3389/fmicb.2021.787451
    https://pubmed.ncbi.nlm.nih.gov/35360652/
  • Vidal-Cevallos P, Torre A, Mendez-Sanchez N, Uribe M, Chavez-Tapia NC. Epidemiological and Genetic Aspects of NAFLD and NASH in Mexico. Clin Liver Dis (Hoboken). 2022 Mar 10;19(2):68-72.
    doi: 10.1002/cld.1167. eCollection 2022 Feb
    https://pubmed.ncbi.nlm.nih.gov/35308477/
  • Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Chávez-Tapia NC Global multi-stakeholder endorsement of the MAFLD definition. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390.
    doi: 10.1016/S2468-1253(22)00062-0
    https://pubmed.ncbi.nlm.nih.gov/35248211/
  • Pérez-Monter C, Álvarez-Arce A, Nuño-Lambarri N, Escalona-Nández I, Juárez-Hernández E, Chávez-Tapia NC, Uribe M, Barbero-Becerra VJ. Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level. Int J Mol Sci. 2022 Jan 17;23(2):991.
    doi: 10.3390/ijms23020991
    https://pubmed.ncbi.nlm.nih.gov/35055177/
  • Rodríguez-Antonio I, López-Sánchez GN, Reyes-Gómez VA, Contreras-Flores EH, Farías-García F, Espejel-Deloiza M, Durán-Padilla MA, Chablé-Montero F, Uribe M, Chávez-Tapia NC, Montalvo-Javé EE, Nuño-Lámbarri N. Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis. Ann Hepatol. 2022 Mar-Apr;27(2):100651.
    doi: 10.1016/j.aohep.2021.100651. Epub 2021 Dec 9
    https://pubmed.ncbi.nlm.nih.gov/34896638/
  • Carnalla M, Vidaña-Pérez D, Alpuche-Aranda C, Chávez-Tapia NC, Romero-Martínez M, Shamah-Levy T, Barrientos-Gutiérrez T. Hepatitis B infection in Mexican adults: Results of a nationally representative survey. Ann Hepatol. 2022 Jan;27 Suppl 1:100583. Epub 2021 Nov 19.
    doi: 10.1016/j.aohep.2021.100583.
    https://pubmed.ncbi.nlm.nih.gov/34808394
  • Chávez-Tapia NC, Tiribelli C. The multifaceted aspects of modern hepatology. Ann Hepatol. 2021 Dec;26:100536.
    doi: 10.1016/j.aohep.2021.100536.
    https://pubmed.ncbi.nlm.nih.gov/34547479
  • Vidal-Cevallos P, Ordóñez-Vázquez AL, Procopio-Mosso O, Cardoso-Arias R, Uribe Chávez-Tapia NC. Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico. M, Sci Rep. 2021 Jun 8;11(1):12100.
    doi: 10.1038/s41598-021-91199-y.
    https://pubmed.ncbi.nlm.nih.gov/34103552
  • Rodríguez-Antonio I, López-Sánchez GN, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N. Role of the inflammasome, gasdermin D, and pyroptosis in non-alcoholic fatty liver disease. Gastroenterol Hepatol. 2021 May 28.
    doi: 10.1111/jgh.15561.
    https://pubmed.ncbi.nlm.nih.gov/34050551
  • Vidal-Cevallos P, Chávez-Tapia N. Very-early-stage Hepatocellular Carcinoma, Are We at Long Last on Route for Achieving Better Patient Outcomes? J Clin Transl Hepatol. 2021 Apr 28;9(2):141-142.
    doi: 10.14218/JCTH.2021.00137
    https://pubmed.ncbi.nlm.nih.gov/34007794
  • Vidal-Cevallos P, Higuera-De-La-Tijera F, Chávez-Tapia NC, Sánchez-Girón F, Reyes EC, Rosales-Salyano VH, Servin-Caamaño A, Vázquez-Medina MU, Méndez-Sánchez N. Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico. Ann Hepatol. 2021 Apr 24;24:100354.
    doi: 10.1016/j.aohep.2021.100354.
    https://pubmed.ncbi.nlm.nih.gov/33901638
  • Mendizabal M, Ridruejo E, Piñero F, Anders M, Padilla M, Toro LG, Torre A, Montes P, Urzúa A, Ballerga EG, Silveyra MD, Michelato D, Díaz J, Peralta M, Pages J, García SR, Lozano IG, Macias Y, Cocozzella D, Chávez-Tapia N, Tagle M, Dominguez A, Varón A, Pozo EV, Tijera FH, Bustios C, Conte D, Escajadillo N, Gómez AJ, Tenorio L, Barradas MC, Schinoni MI, Bessone F, Contreras F, Nazal L, Sanchez A, García M, Brutti J, Cabrera MC, Miranda-Zazueta G, Rojas G, Cattaneo M, Castro-Narro G, Rubinstein F, Silva MO. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection. Ann Hepatol. 2021 Apr 14;100350.
    doi: 10.1016/j.aohep.2021.100350
    https://pubmed.ncbi.nlm.nih.gov/33864948
  • Vidal-Cevallos P, Higuera-De-La-Tijera F, Chávez-Tapia NC, Sanchez-Giron F, Cerda-Reyes E, Rosales-Salyano VH, Servin-Caamaño A, Vázquez-Medina MU, Méndez-Sánchez N. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study. Ann Hepatol. 2021 Feb 26;24:100338.
    doi: 10.1016/j.aohep.2021.100338
    https://pubmed.ncbi.nlm.nih.gov/33647501
  • López-Méndez Iván, Méndez-Maldonado Karla, Manzo-Francisco Luis A, Juárez-Hernández Eva, Uribe Misael, Barbero-Becerra Varenka J. G protein-coupled receptors: Key molecules in metabolic associated fatty liver disease development. Nutr Res. 2021 Mar;87:70-79. doi: 10.1016/j.nutres.2020.12.019. Epub 2020 Dec 24.
    https://pubmed.ncbi.nlm.nih.gov/33601216/
  • Romano-Munive AF, García-Correa JJ, García-Contreras LF, Ramírez-García J, Uscanga L, Barbero-Becerra VJ, Moctezuma-Velázquez C, Ochoa-Rubí JA, Toledo-Cuque J, Vázquez-Anaya G, Keil-Ríos D, Grajales-Figueroa G, Ramírez-Luna MÁ, Valdovinos-Andraca F, Zamora-Nava LE, Tellez-Avila F. Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind, multicentre, placebo controlled, randomised clinical trial. BMJ Open Gastroenterol. 2021 Feb;8(1):e000562.
    doi:10.1136/bmjgast-2020-000562.
    https://pubmed.ncbi.nlm.nih.gov/33558263
  • Botello-Manilla AE, López-Sánchez GN, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Hepatic steatosis and respiratory diseases: a new panorama. Ann Hepatol. 2021 Sep-Oct;24:100320. Epub 2021 Feb 4.
    doi: 10.1016/j.aohep.2021.
    https://pubmed.ncbi.nlm.nih.gov/33549735
  • Valdivia-Correa B, Reynier-Garza V, Chávez-Tapia N, Alanis-Estrada G, Araiza-Garaygordobil D. Acute heart failure following transjugular intrahepatic portal-systemic shunting corrected through transient balloon occlusion. Rev Gastroenterol Mex. Apr-Jun 2021;86(2):195-197.
    doi: 10.1016/j.rgmx.2020.04.009. Epub 2021 Jan 30.
    https://pubmed.ncbi.nlm.nih.gov/33531166
  • Botello-Manilla AE, López-Sánchez GN, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Hepatic steatosis and respiratory diseases: a new panorama. Ann Hepatol. 2021 Feb 4;24:100320. doi: 10.1016/j.aohep.2021.100320.
    https://pubmed.ncbi.nlm.nih.gov/33549735
  • Valdivia-Correa B, Reynier-Garza V, Chávez-Tapia N, Alanis-Estrada G, Araiza-Garaygordobil D. Acute heart failure following transjugular intrahepatic portal-systemic shunting corrected through transient balloon occlusion. Rev Gastroenterol Mex. Apr-Jun 2021;86(2):195-197.
    doi: 10.1016/j.rgmx.2020.04.009. Epub 2021 Jan 30.
    https://pubmed.ncbi.nlm.nih.gov/33531166
  • Calderón-Esquivel Néstor, Vázquez-Flores A David, González-Chon Octavio, García-Briones Alondra, Gutiérrez-Villaseñor Alan O, Romero-González Juan P, Juárez-Hernández Eva, Sosa-García J Ojino. [Correlación de variables ecocardiográficas y biomarcadores en pacientes graves con COVID-19]. Cir Cir. 2020 Dec 9.
    doi: 10.24875/CIRU.20000900.
    https://pubmed.ncbi.nlm.nih.gov/33296911/
  • Mendez-Sanchez N, Arrese M, Gadano A, Oliveira CP, Fassio E, Arab JP, Chávez-Tapia NC, Dirchwolf M, Torre A, Ridruejo E, Pinchemel-Cotrim H, Castellanos Fernández MI, Uribe M, Girala M, Diaz-Ferrer J, Restrepo JC, Padilla-Machaca M, Dagher L, Gatica M, Olaechea B, Pessôa MG, Silva M. The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):65-72.
    doi: 10.1016/S2468-1253(20)30340-X
    https://pubmed.ncbi.nlm.nih.gov/33181118
  • López-Méndez Iván, Aquino-Matus Jorge, Murua-Beltrán Gall Sofia, Prieto-Nava José D, Juárez-Hernández Eva, Uribe Misael, Castro-Narro Graciela. Ann Hepatol. Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
    2021 Jan-Feb;20:100271. doi: 10.1016/j.aohep.2020.09.015
    https://pubmed.ncbi.nlm.nih.gov/33099028/
  • Sosa-García J Ojino, Gutiérrez-Villaseñor Alan O, García-Briones Alondra, Romero-González Juan P, Juárez-Hernández Eva, González-Chon Octavio. Experience in the management of severe COVID-19 patients in an intensive care unit. Cir Cir. 2020;88(5):569-575.
    doi: 10.24875/CIRU.20000675
    https://pubmed.ncbi.nlm.nih.gov/33064694/
  • Rodríguez-Antonio I, López-Sánchez GN, Garrido-Camacho VY, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N. Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. HPB (Oxford). 2020 Aug 6;S1365-182X(20)31105-9.
    doi: barbero10.1016/j.hpb.2020.07.011
    https://pubmed.ncbi.nlm.nih.gov/32773176
  • López-Bautista F, Barbero-Becerra VJ, Ríos MY, Ramírez-Cisneros MÁ, Sánchez-Pérez CA, Ramos-Ostos MH, Uribe M, Chávez-Tapia NC, Juárez-Hernández E. Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients. Ann Hepatol. Sep-Oct 2020;19(5):482-488.
    doi: 10.1016/j.aohep.2020.06.008.
    https://pubmed.ncbi.nlm.nih.gov/32717363
  • Vidal-González D, López-Sánchez GN, Concha-Rebollar LA, Rodríguez-Herrera A, Morales-Ramirez F, Chávez-Tapia N, Uribe M, Nader-Kawachi JA, Nuño-Lámbarri N. Cerebral hemodynamics in the non-alcoholic fatty liver. Ann Hepatol. 2020 Jul 16:S1665-2681(20)30067-3.
    doi: 10.1016/j.aohep.2020.06.006.
    https://pubmed.ncbi.nlm.nih.gov/32683094
  • Botello-Manilla AE, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Genetics and epigenetics purpose in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2020 Aug;14(8):733-748.
    doi:10.1080/17474124.2020.1780915.
    https://pubmed.ncbi.nlm.nih.gov/32552211
  • Martínez-Zavala N, López-Sánchez GN, Vergara-Lopez A, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Vitamin D deficiency in Mexicans have a high prevalence: a cross-sectional analysis of the patients from the Centro Médico Nacional 20 de Noviembre. Arch Osteoporos. 2020 Jun 16;15(1):88.
    doi: 10.1007/s11657-020-00765-w.
    https://pubmed.ncbi.nlm.nih.gov/32542548
  • López-Sánchez GN, Dóminguez-Pérez M, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease. Ann Hepatol. 2020 Jun 6;S1665-2681.
    doi: 10.1016/j.aohep.2020.04.012
    https://pubmed.ncbi.nlm.nih.gov/32533953
  • Valencia-Rodríguez A, Vera-Barajas A, Chávez-Tapia NC, Uribe M, Méndez-Sánchez N. Looking Into a New Era for the Approach of Metabolic (Dysfunction) Associated Fatty Liver Disease. Ann Hepatol.2020;19(3):227-229.
    doi: 10.1016/j.aohep.2020.04.001.
    https://pubmed.ncbi.nlm.nih.gov/32359519
  • Barbero-Becerra VJ, López-Méndez I, Romo-Araiza A, Visag-Castillo V, Chávez-Tapia NC, Uribe M, Juárez-Hernández E. Sarcopenia in Chronic Liver Diseases: A Translational Overview. Expert Rev Gastroenterol Hepatol. 2020;14(5):355-366.
    doi: 10.1080/17474124.2020.1757427.
    https://pubmed.ncbi.nlm.nih.gov/32299261
  • Salva-Pastor N, López-Sánchez GN, Chávez-Tapia NC, Audifred-Salomón JR, Niebla-Cárdenas D, Topete-Estrada R, Pereznuñez-Zamora H, Vidaltamayo-Ramírez R, Báez-Arellano ME, Uribe M, Nuño-Lámbarri N. Polycystic Ovary Syndrome With Feasible Equivalence to Overweight as a Risk Factor for Non-Alcoholic Fatty Liver Disease Development and Severity in Mexican Population. Ann Hepatol.2020;5:S1665-2681.
    doi: 10.1016 / j.aohep.2020.01.004
    https://pubmed.ncbi.nlm.nih.gov/32111488
  • Salva-Pastor N, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider. Gastroenterol Hepatol Bed Bench. 2019 Fall;12(4):267-277.
    PMCID: PMC6820831
    https://www.ncbi.nlm.nih.gov/pubmed/31749914
  • Juárez-Hernández E, Uribe M. The lack of guidelines and government policies for regulating nonprescription sale of antibiotics and its medical consequences.1 Ann Hepatol. 2019;18(6):783-785.
    doi: 10.1016/j.aohep.2019.10.001
    https://www.ncbi.nlm.nih.gov/pubmed/31735347
  • Chávez-Tapia N. The bidirectional relationship between viral hepatitis infections and work. Ann Hepatol. 2019;18(5):655.
    doi: 10.1016 / j.aohep.2019.07.001
    https://www.ncbi.nlm.nih.gov/pubmed/31416707
  • Salva-Pastor N, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol. 2019;2;194:105445.
    doi: 10.1016/j.jsbmb.2019.105445
    https://www.ncbi.nlm.nih.gov/pubmed/31381969
  • López-Sánchez GN, Dóminguez-Pérez M, Uribe M, Nuño-Lámbarri N. The fibrogenic process and the unleashing of acute-on-chronic liver failure. Clinical and Molecular Hepatology. 2019:14.
    doi: 10.3350/cmh.2019.0011.
    https://www.ncbi.nlm.nih.gov/pubmed/31195778
  • Solsona-Vilarrasa E, Fucho R, Torres S, Nuñez S, Nuño-Lámbarri N, Enrich C, García-Ruiz C, Fernández-Checa JC. Cholesterol enrichment in liver mitochondria impairs oxidative phosphorylation and disrupts the assembly of respiratory supercomplexes.Redox Biology. 2019;24:101214.
    doi: 10.1016/j.redox.2019.101214.
    https://www.ncbi.nlm.nih.gov/pubmed/31108462
  • Bernal-Reyes R, Castro-Narro G, Malé-Velázquez R, Carmona-Sánchez R, González-Huezo MS, García-Juárez I, Chávez-Tapia N, et al. The Mexican consensus on nonalcoholic fatty liver disease. Revista de Gastroenterología de México 2019;84(1):69-99.
    doi: 10.1016/j.rgmx.2018.11.007.
    https://www.ncbi.nlm.nih.gov/pubmed/30711302
  • Domínguez-Pérez M, Simoni-Nieves A, Rosales P, Nuño-Lámbarri N, Rosas-Lemus M, Souza V, et al. Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis. Journal of Cellular Physiology. 2019;234(5):7213-7223.
    doi:10.1002/jcp.27474
    https://www.ncbi.nlm.nih.gov/pubmed/30239004
  • Bazerbachi F, Haffar S, Wang Z, González JC, Arias-Loste MT, Crespo J, Darwish-Murad S, Ikram MA, Olynyk JK, Gan E, Petta S, Berzuini A, Prati D, de Lédinghen V, Wong VW, Del Poggio P, Chávez-Tapia NC, et al. Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals. Clin Gastroenterol Hepatol. 2019;17(1):54-64.e1.
    doi: 10.1016/j.cgh.2018.08.069.
    https://pubmed.ncbi.nlm.nih.gov/30196155

 

Contáctanos

Fundación:
(55) 5424 7268
Lunes a viernes:
8:00 am a 17:00 hrs.
Sábado:
9:00 am a 12:00 hrs.

Dispensario:
(55) 5424 7272
Lunes a viernes:
8:00 am a 17:00 hrs.

Comité de Ética e Investigación para Estudios en Humanos:
(55) 5424 7200 ext.4157
Lunes a viernes, 8:00 a 17:00 hrs.

Sillón de Mendoza 110, Col. Toriello Guerra C.P. 14050.
fundacioncms@medicasur.org.mx

55 7223 5449
Solo mensajes

Dona
Acerca de Médica Sur
Contáctanos